Clindamycin Injection, Solution
Product Images NDC 0404-9838

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 0404-9838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
Clindamycin is an antibacterial agent that can cause Clostridium difficile-associated diarrhea (CDAD), which can range from mild to fatal. CDAD is caused by the overgrowth of C. difficile in the colon due to the alteration of the normal flora by antibacterial agents. Severe colitis, which can be fatal, has also been associated with clindamycin therapy. Clindamycin should only be used in serious infections where less toxic options are not appropriate and not used in patients with nonbacterial infections. CDAD must be considered in all patients with diarrhea following antibiotic use, and appropriate management should be instituted, including discontinuation of ongoing antibiotics, fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation as clinically indicated.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
Table 1 shows the average peak and trough serum concentrations of active clindamycin after dosing with clindamycin phosphate in healthy adult males and pediatric patients. The dosage regimens and corresponding serum concentrations are provided for intravenous and intramuscular administration. Data for the pediatric patients group was obtained from patients being treated for infection.*
FDA Label Image

Image3.jpg (Image3)

FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
This appears to be a medication administration chart detailing the dosage (in milligrams), diluent (in milliliters), and time it takes to administer the medication via IV infusion. The first column shows a dosage of 300mg, the second column shows a diluent of 50mL, and the third column shows a time of 10 minutes. The same pattern follows for the subsequent rows, with increasing dosages and diluents resulting in longer administration times. This chart could be used by healthcare professionals to ensure accurate medication dosing and administration.*
FDA Label Image

Image5.jpg (Image5)

Image5.jpg (Image5)
Clindamycin Injection, USP is available in different strengths and presentations such as 150mg per mL, 300mg per 2 mL Single-Dose Vial, 600mg per 4 mL Single-Dose Vial, and 900mg per 6 mL Single-Dose Vial. These presentations come in 25 vials per carton. The Pharmacy Bulk Package is available with 9,000mg per 60mL bottle and one bottle per carton. The NDC numbers are provided for each presentation.*
FDA Label Image

Image6.jpg (Image6)

Image6.jpg (Image6)
The text is a reference citation to an article titled "Evaluation of CLEOCIN HCL and CLEOCIN Phosphate in an Aged Population" by Smith RB and Phillips JP, which was published in Upjohn TR 8147-82-9122-021 in December 1982. It does not provide any further information.*
FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
M CLINDAMYCIN 300MG PER 2ML, 150mg Injection, USP is a single dose vial that comes in a pack of 10 use. It must be diluted before intravenous use. The medication should only be administered by a medical professional. It is advised to keep it out of children's reach. The product should be stored according to the instructions on the manufacturer's insert. The product is packaged by Hemy Sehein, Inc. and has a LOT# XOO00OKKXK. The expiration date is indicated as mm-yy.*
FDA Label Image

Label2.jpg (Label2)

Label2.jpg (Label2)
This is a description of Clindamycin, an injectable medicine with a strength of 600 milligrams per 4 milliliters. It comes in a single dose vial for intramuscular or intravenous use. The container is sterile, non-pyrogenic, and should be kept away from children. The injection must be diluted before intravenous use. The bottle closure is not made of natural rubber latex. It should be stored at room temperature, not refrigerated. There is a product item number and a lot number on the container, but no information on the indication or usage of the medicine.*
FDA Label Image

Label3.jpg (Label3)

Label3.jpg (Label3)
CLINDAMYCIN is a medication that comes in a 150mg single dose vial that contains 900g per BMI. It is used for intramuscular or intravenous purposes and should be diluted if given intravenously. It is sterile, nonpyrogenic, and the container closing is not made with natural rubber. The medication should be kept out of reach of children and should be stored at room temperature not higher than 26C (68F). The medication should not be refrigerated. The item number for the medication is 2480926 and the GTIN code is not readable. The product is packaged by Henry Schein, Inc. and has an expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.